share_log

Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scadden David

SEC ·  Dec 14 05:06
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.